Repurposing Empagliflozin for DMD-associated Cardiomyopathy in Children 6-18 Years of Age

NCT06643442 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

DMD-associated Dilated Cardiomyopathy

Interventions

DRUG: Empagliflozin Tablets

Sponsor

Sebastiano Lava

Collaborators

[object Object]
[object Object]
[object Object]